FlowCardia completes enrollment for catheter study

TriMed Staff | September 12, 2007 | Health Imaging | Cardiac Imaging

Medical device company FlowCardia has announced the completion of enrollment into its U.S. peripheral approach to recanalization in occluded totals (PATRIOT) study, which includes eight hospitals and 85 patients and is designed to assess the safety and efficacy of its line of Crosser catheters in lower limb chronic total occlusions (CTOs).

According to the Sunnyvale, Calif.-based FlowCardia, the Crosser is a rapid exchange catheter delivered over standard .014-inch and .018-inch guidewires to the site of a CTO.

TriMed Staff

Around the web

Cardiovascular Business

Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business

‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.

FlowCardia completes enrollment for catheter study

Related Content

Around the web